AAAAAA
Results:
1-14
|
Results: 14
Authors:
Hemminki, A
Belousova, N
Zinn, KR
Liu, B
Wang, MH
Chaudhuri, TR
Rogers, BE
Buchsbaum, DJ
Siegal, GP
Barnes, MN
Gomez-Navarro, J
Curiel, DT
Alvarez, RD
Citation: A. Hemminki et al., An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression, MOL THER, 4(3), 2001, pp. 223-231
Authors:
Casado, E
Gomez-Navarro, J
Yamamoto, M
Adachi, Y
Coolidge, CJ
Arafat, WO
Barker, SD
Wang, MH
Mahasreshti, PJ
Hemminki, A
Gonzalez-Baron, M
Barnes, MN
Pustilnik, TB
Siegal, GP
Alvarez, RD
Curiel, DT
Citation: E. Casado et al., Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications, CLIN CANC R, 7(8), 2001, pp. 2496-2504
Authors:
Mahasreshti, PJ
Navarro, JG
Kataram, M
Wang, MH
Carey, D
Siegal, GP
Barnes, MN
Nettelbeck, DM
Alvarez, RD
Hemminki, A
Curiel, DT
Citation: Pj. Mahasreshti et al., Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma, CLIN CANC R, 7(7), 2001, pp. 2057-2066
Authors:
Casado, E
Nettelbeck, DM
Gomez-Navarro, J
Hemminki, A
Baron, MG
Siegal, GP
Barnes, MN
Alvarez, RD
Curiel, DT
Citation: E. Casado et al., Transcriptional targeting for ovarian cancer gene therapy, GYNECOL ONC, 82(2), 2001, pp. 229-237
Authors:
Barker, SD
Casado, E
Gomez-Navarro, J
Xiang, J
Arafat, W
Mahasreshti, P
Pustilnik, TB
Hemminki, A
Siegal, GP
Alvarez, RD
Curiel, DT
Citation: Sd. Barker et al., An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites, GYNECOL ONC, 82(1), 2001, pp. 57-63
Authors:
Hemminki, A
Joensuu, H
Citation: A. Hemminki et H. Joensuu, Microsatellite instability as a molecular marker for very good survival incolorectal cancer patients receiving adjuvant chemotherapy - Reply, GASTROENTY, 120(5), 2001, pp. 1309-1310
Authors:
Hemminki, A
Dmitriev, I
Liu, B
Desmond, RA
Alemany, R
Curiel, DT
Citation: A. Hemminki et al., Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule, CANCER RES, 61(17), 2001, pp. 6377-6381
X-ray studies of recombinant anti-testosterone Fab fragments: the use of PEC 3350 in crystallization
Authors:
Valjakka, J
Hemminki, A
Teerinen, T
Takkinen, K
Rouvinen, J
Citation: J. Valjakka et al., X-ray studies of recombinant anti-testosterone Fab fragments: the use of PEC 3350 in crystallization, ACT CRYST D, 56, 2000, pp. 218-221
Authors:
Hemminki, A
Mecklin, JP
Jarvinen, H
Aaltonen, LA
Joensuu, H
Citation: A. Hemminki et al., Microsatellite instability is a favorable prognostic indicator in patientswith colorectal cancer receiving chemotherapy, GASTROENTY, 119(4), 2000, pp. 921-928
Authors:
Hemminki, A
Citation: A. Hemminki, The molecular basis and clinical aspects of Peutz-Jeghers syndrome, CELL MOL L, 55(5), 1999, pp. 735-750
Authors:
Roth, S
Sistonen, P
Salovaara, R
Hemminki, A
Loukola, A
Johansson, M
Avizienyte, E
Cleary, KA
Lynch, P
Amos, CI
Kristo, P
Mecklin, JP
Kellokumpu, I
Jarvinen, H
Aaltonen, LA
Citation: S. Roth et al., SMAD genes in juvenile polyposis, GENE CHROM, 26(1), 1999, pp. 54-61
Authors:
Ylikorkala, A
Avizienyte, E
Tomlinson, IPM
Tiainen, M
Roth, S
Loukola, A
Hemminki, A
Johansson, M
Sistonen, P
Markie, D
Neale, K
Phillips, R
Zauber, P
Twama, T
Sampson, J
Jarvinen, H
Makela, TP
Aaltonen, LA
Citation: A. Ylikorkala et al., Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer, HUM MOL GEN, 8(1), 1999, pp. 45-51
Authors:
Hemminki, A
Citation: A. Hemminki, Inherited predisposition to gastrointestinal cancer: The molecular backgrounds of Peutz-Jeghers syndrome and hereditary non-polyposis colorectal cancer, ANN CHIR GY, 88(1), 1999, pp. 73-74
Authors:
Avizienyte, E
Loukola, A
Roth, S
Hemminki, A
Tarkkanen, M
Salovaara, R
Arola, J
Butzow, R
Husgafvel-Pursiainen, K
Kokkola, A
Jarvinen, H
Aaltonen, LA
Citation: E. Avizienyte et al., LKB1 somatic mutations in sporadic tumors, AM J PATH, 154(3), 1999, pp. 677-681
Risultati:
1-14
|